Page 9 - BH-2-4
P. 9

Brain & Heart                                                          Cardiac sarcoidosis with AVB and VA




            Table 1. Diagnostic criteria for CS as outlined by JCS, HRS, and WASOG 13‑15
            JCS 2016  CS with systemic involvement                     Isolated CS
                      Diagnosis confirmed histologically through endomyocardial biopsy  Diagnosis confirmed histologically through
                      OR                                               endomyocardial biopsy
                      Major criteria*                                  OR
                       High-degree AVB or fatal VA                     67  Ga citrate scintigraphy or 18F-FDG PET revealing
                       LV contractile dysfunction                      abnormally high tracer accumulation in the heart
                       67  Ga citrate scintigraphy or 18F-FDG PET revealing abnormally high   AND three of the following
                       tracer accumulation in the heart                 High-degree AVB or fatal VA
                       LGE of the myocardium on CMR                     LV contractile dysfunction
                       Basal thinning of ventricular septum or abnormal ventricular wall   LGE of the myocardium on CMR
                       anatomy                                          Basal thinning of the ventricular septum or abnormal
                      Minor criteria                                    ventricular wall anatomy
                       Abnormal ECG findings: VA, bundle branch block, axis deviation,   AND all of the following
                       abnormal Q waves                                 No clinical findings of sarcoidosis in organs other than
                       Perfusion defect on perfusion scintigraphy       the heart
                       Monocyte infiltration and moderate-to-severe myocardial interstitial fibrosis  Chest CT showing no hilar lymphadenopathy or shadows
                       AND                                              along the lymphatic tracts
                       Granulomas found in other organs in addition to the heart  67  Ga scintigraphy or 18F-FDG PET revealing no
                       OR                                               abnormal tracer accumulation in organs other than the
                       Clinical findings suggestive of sarcoidosis in either the respiratory tract   heart
                       or eyes
                       AND
                      The presence of two of the following criteria
                       • Bilateral hilar lymphadenopathy
                       • Raised serum angiotensin‑converting enzyme activity or lysozyme levels
                       • High soluble interleukin‑2 receptor levels
                       •  Significant tracer accumulation on  Ga citrate scintigraphy or
                                               67
                        18F-FDG PET
                       •  High percentage of lymphocytes with a CD4/CD8 ratio of >3.5 in
                        bronchoalveolar lavage fluid
                      *Where endomyocardial biopsy is negative, either two major or one major
                      criterion and two or more minor criteria are required to make a diagnosis of CS
            HRS 2014  Diagnosis confirmed based on histological finding of non-caseating granulomas on endomyocardial biopsy
                      Diagnosis of CS is probable if extracardiac sarcoidosis is confirmed and one or more of the following criteria are satisfied:
                      Immunosuppressant-responsive cardiomyopathy or AVB
                      Unexplained LVEF <40%
                      Unexplained sustained VT or high-degree AVB
                      Patchy FDG uptake on cardiac PET in a pattern consistent with that of CS
                      LGE on CMR
                      Positive gallium uptake in a pattern consistent with that of CS
            WASOG 2014 Granulomatous inflammation demonstrated in one other organ and one of the following criteria is satisfied:
                      Treatment-responsive cardiomyopathy or AVB
                      Reduced LVEF in the absence of other risk factors
                      Spontaneous or inducible VT with no other risk factors
                      Mobitz II or complete heart block
                      Positive gallium uptake in a pattern consistent with that of CS
                      LGE or T2 prolongation on CMR
                      Defect on perfusion scintigraphy
            Abbreviations: 18F-FDG PET: 18-Fluorodeoxyglucose positron emission tomography; AVB: Atrioventricular block; CMR: Cardiac magnetic resonance
            imaging; CS: Cardiac sarcoidosis; CT: Computerized tomography; ECG: Electrocardiogram; HRS: Heart Rhythm Society; JCS: Japanese Circulation
            Society; LGE: Late gadolinium enhancement; LV: Left ventricle; LVEF: Left ventricular ejection fraction; VA: Ventricular arrhythmia; VT: Ventricular
            tachycardia; WASOG: World Association on Sarcoidosis and Other Granulomatous Disorders.

            Furthermore, a reduced left ventricular ejection fraction   basal septum is a major diagnostic criterion according to
            (LVEF) is a significant independent risk factor for   the JCS guidelines. 13
            mortality.  Detection of echocardiographic findings at the   A study by Di Stefano et al.  explored the use of left
                    21
                                                                                        22
            initial presentation with AVB and VAs is associated with   and right ventricular  global  longitudinal  strain  assessed
            earlier diagnosis and treatment of CS. 10,13  Thinning of the   through speckle-tracking echocardiography. They found a


            Volume 2 Issue 4 (2024)                         3                                doi: 10.36922/bh.3515
   4   5   6   7   8   9   10   11   12   13   14